1. Home
  2. FLXS vs TLSI Comparison

FLXS vs TLSI Comparison

Compare FLXS & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexsteel Industries Inc.

FLXS

Flexsteel Industries Inc.

HOLD

Current Price

$76.89

Market Cap

290.6M

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$4.87

Market Cap

270.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLXS
TLSI
Founded
2001
2010
Country
United States
United States
Employees
N/A
102
Industry
Home Furnishings
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
290.6M
270.2M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
FLXS
TLSI
Price
$76.89
$4.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$54.00
$7.00
AVG Volume (30 Days)
37.0K
208.5K
Earning Date
04-20-2026
05-12-2026
Dividend Yield
1.41%
N/A
EPS Growth
N/A
N/A
EPS
3.63
N/A
Revenue
$441,073,000.00
N/A
Revenue This Year
$4.51
$35.45
Revenue Next Year
$4.89
$37.58
P/E Ratio
$21.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$32.65
$2.20
52 Week High
$79.70
$7.95

Technical Indicators

Market Signals
Indicator
FLXS
TLSI
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
FLXS
TLSI

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Share on Social Networks: